This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
RAT ANTI MOUSE CD282
catalog :
MCA2266
quantity :
0.25 mg
price :
695 USD
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
6C2
reactivity :
mouse
application :
immunoprecipitation, flow cytometry
product information
EntityType :
Monoclonal Antibody
EntityCategory :
Antibodies
ProductCode :
MCA2266
Description :
RAT ANTI MOUSE CD282
Specificity :
CD282
TargetSpecies :
Mouse
Host :
Rat
Format :
Purified
Isotypes :
IgG2a
Applications :
IP,F
ApplicationTypes :
Immunoprecipitation,Flow Cytometry
Clone :
6C2
Quantity :
0.25 mg
QuantityValue :
0.25
QuantityType :
mg
GOAccessions :
GO:0071224,GO:0052063,GO:0060907,GO:0070891,GO:0071223,GO:0042497,GO:0042498,GO:0042535,GO:0042892,GO:0045087,GO:0045429,GO:0046982,GO:0051770,GO:0002687,GO:0002752,GO:0002755,GO:0016021,GO:0002238,GO:0004888,GO:0006954,GO:0050830,GO:0009897,GO:0010552,GO:0030670,GO:0032695,GO:0032700,GO:0032722,GO:0032728,GO:0032735,GO:0032741,GO:0032755,GO:0032760,GO:0044130,GO:0035355
GOTerms :
response to fungus associated molecule,activation of leukocyte migration,positive regulation of immune cell migration,positive regulation of leucocyte migration,stimulation of leukocyte migration,up regulation of leukocyte migration,upregulation of leukocyte migration,up-regulation of leukocyte migration,cell surface PAMP receptor signaling pathway,cell surface pathogen receptor signaling pathway,cell surface pattern recognition receptor signalling pathway,cell surface PRR signaling pathway,MyD88-dependent TLR signaling pathway,MyD88-dependent toll-like receptor signalling pathway,transmembrane,GO:0004926,non G protein coupled 7TM receptor activity,non-G-protein coupled 7TM receptor activity,non-G-protein-coupled 7TM receptor activity,defence response to Gram-positive bacteria,defence response to Gram-positive bacterium,defense response to Gram-positive bacteria,Gram-positive antibacterial peptide activity,juxtamembrane,outer surface of cytoplasmic membrane,phagosome membrane,down regulation of interleukin-12 production,down-regulation of interleukin-12 production,downregulation of interleukin-12 production,inhibition of interleukin-12 production,negative regulation of IL-12 production,down regulation of interleukin-17 production,down-regulation of interleukin-17 production,downregulation of interleukin-17 production,inhibition of interleukin-17 production,negative regulation of IL-17 production,activation of chemokine production,stimulation of chemokine production,up regulation of chemokine production,upregulation of chemokine production,up-regulation of chemokine production,activation of interferon-beta production,positive regulation of IFN-beta production,stimulation of interferon-beta production,up regulation of interferon-beta production,up-regulation of interferon-beta production,upregulation of interferon-beta production,activation of interleukin-12 production,positive regulation of IL-12 production,stimulation of interleukin-12 production,up regulation of interleukin-12 production,up-regulation of interleukin-12 production,upregulation of interleukin-12 production,activation of interleukin-18 production,positive regulation of IL-18 production,stimulation of interleukin-18 production,up regulation of interleukin-18 production,up-regulation of interleukin-18 production,upregulation of interleukin-18 production,activation of interleukin-6 production,positive regulation of IL-6 production,stimulation of interleukin-6 production,up regulation of interleukin-6 production,up-regulation of interleukin-6 production,upregulation of interleukin-6 production,activation of tumor necrosis factor production,positive regulation of TNF production,positive regulation of TNF-alpha production,positive regulation of tumor necrosis factor-alpha production,stimulation of tumor necrosis factor production,up regulation of tumor necrosis factor production,upregulation of tumor necrosis factor production,up-regulation of tumor necrosis factor production,TLR2-TLR6 protein complex,bacterial triacyl lipopeptide binding,bacterial triacyl lipoprotein binding,triacylated lipopeptide binding,bacterial diacyl lipopeptide binding,bacterial diacyl lipoprotein binding,diacylated lipopeptide binding,activation of tumor necrosis factor biosynthetic process,positive regulation of TNF alpha biosynthesis,positive regulation of TNF alpha biosynthetic process,positive regulation of TNF biosynthesis,positive regulation of TNF biosynthetic process,positive regulation of TNF-alpha biosynthesis,positive regulation of TNF-alpha biosynthetic process,positive regulation of tumor necrosis factor anabolism,positive regulation of tumor necrosis factor biosynthesis,positive regulation of tumor necrosis factor formation,positive regulation of tumor necrosis factor synthesis,positive regulation of tumor necrosis factor-alpha biosynthesis,positive regulation of tumor necrosis factor-alpha biosynthetic process,stimulation of tumor necrosis factor biosynthetic process,up regulation of tumor necrosis factor biosynthetic process,upregulation of tumor necrosis factor biosynthetic process,up-regulation of tumor necrosis factor biosynthetic process,GO:0002226,nonspecific immune response,activation of nitric oxide biosynthetic process,positive regulation of nitric oxide anabolism,positive regulation of nitric oxide biosynthesis,positive regulation of nitric oxide formation,positive regulation of nitric oxide synthesis,stimulation of nitric oxide biosynthetic process,up regulation of nitric oxide biosynthetic process,upregulation of nitric oxide biosynthetic process,up-regulation of nitric oxide biosynthetic process,activation of nitric-oxide synthase biosynthetic process,positive regulation of NO synthase biosynthesis,positive regulation of NO synthase biosynthetic process,positive regulation of NOS biosynthesis,positive regulation of NOS biosynthetic process,stimulation of nitric-oxide synthase biosynthetic process,up regulation of nitric-oxide synthase biosynthetic process,up-regulation of nitric-oxide synthase biosynthetic process,upregulation of nitric-oxide synthase biosynthetic process,activation by organism of defense-related host nitric oxide production,activation by organism of defense-related host NO production,induction by organism of defense-related host NO production,cellular response to LTA
UniprotAccessions :
Q9QUN7
Gene :
Tlr2
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=24088
PublishedSynonyms :
TLR2
EntityFormats :
ALEXA FLUOR® 488,Purified
UNSPSC :
41116161
Concentration :
IgG concentration 0.5 mg/ml
ProductForm :
Purified IgG - liquid
PriceGBP :
376
PriceEUR :
451
PriceUSD :
695 USD
PriceCHF :
491.59
PriceSEK :
4740
PriceNOK :
4830
PriceDKK :
3364
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
questions and comments